This Article Full Text Full Text (PDF) All Versions of this Article: 34/8/2000    most recent 01.STR.0000079817.68944.1Ev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leker, R. R. Articles by Ovadia, H. Search for Related Content PubMed PubMed Citation Articles by Leker, R. R. Articles by Ovadia, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB TETRAHYDROCANNABINOL Related Collections Animal models of human disease Acute Stroke Syndromes Neuroprotectors

(Stroke. 2003;34:2000.)
© 2003 American Heart Association, Inc.

Original Contributions

Drug-Induced Hypothermia Reduces Ischemic Damage

Effects of the Cannabinoid HU-210

From the Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah University Hospital (R.R.L., N.G., H.O.), and Department of Medicinal Chemistry and Natural Products, Faculty of Medicine, Hebrew University Medical School (R.M.), Jerusalem, Israel.

Correspondence to R.R. Leker, MD, NIH/NINDS, Laboratory of Molecular Biology, Bldg 36, Room 3c12, 36 Convent Dr, MSC 4092, Bethesda, MD 20892. E-mail lekerR{at}nih.ninds.gov

Background and Purpose— Cannabinoids confer neuroprotection in several experimental paradigms, but the responsible mechanisms remain unknown. Therefore, we sought to examine whether the synthetic CB1 agonist HU-210 is capable of reducing ischemic damage and to determine the mechanisms responsible for such protection.

Methods— Sprague-Dawley rats underwent permanent middle cerebral artery occlusion (PMCAO). After dose-response and therapeutic time window-finding experiments, the rats were injected with HU-210 (45 µg/kg IV) or vehicle 1 hour after PMCAO. Physiological parameters and cerebral blood flow in the peri-infarct zone were monitored. The animals were examined with a motor disability scale, and the infarct volumes were measured 72 hours later. We also examined the effects of the selective CB1 antagonist SR-141716 and of controlled warming on the neuroprotection conferred by HU-210.

Results— HU-210 reduced blood pressure and heart rate but did not alter the cerebral blood flow in the infarct border zone. Motor disability and infarct volumes were significantly reduced (by up to 77%; P<0.05) in animals treated with HU-210. A single injection of HU-210 significantly lowered the body temperature compared with vehicle as measured both at 1 hour (32.3±1.3°C versus 35±1.6°C; P=0.0024) and at 24 hours (31.5±2.5°C versus 37.25±0.3°C; P=0.0031) after PMCAO. The protective effects of HU-210 were partially reversed by pretreatment with SR-141716 but were completely abolished by warming of the animals to the levels observed in controls.

Conclusions— HU-210 confers robust protection against ischemic damage. This protection is mediated at least in part by binding to CB1 receptors and is also associated with the indirect protective effects of hypothermia.

Key Words: cannabinoids • cerebral ischemia • hypothermia • neuroprotection • rats

This article has been cited by other articles:

				K. P. Doyle, K. L. Suchland, T. M.P. Ciesielski, N. S. Lessov, D. K. Grandy, T. S. Scanlan, and M. P. Stenzel-Poore Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury Stroke, September 1, 2007; 38(9): 2569 - 2576. [Abstract] [Full Text] [PDF]

				U. Koedel, U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H.-W. Pfister, and C. J. Kirschning Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses Am. J. Pathol., July 1, 2007; 171(1): 200 - 213. [Abstract] [Full Text] [PDF]

				S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey-White, A. Jafri, G. Hasko, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury FASEB J, June 1, 2007; 21(8): 1788 - 1800. [Abstract] [Full Text] [PDF]

				R. R. Leker, F. Soldner, I. Velasco, D. K. Gavin, A. Androutsellis-Theotokis, and R. D.G. McKay Long-Lasting Regeneration After Ischemia in the Cerebral Cortex * Supplemental Materials and Methods Stroke, January 1, 2007; 38(1): 153 - 161. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				C. Di Filippo, F. Rossi, S. Rossi, and M. D'Amico Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN J. Leukoc. Biol., March 1, 2004; 75(3): 453 - 459. [Abstract] [Full Text] [PDF]